ABLE Financial Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$280K Hold
1,000
0.05% 186
2026
Q1
$267K Hold
1,000
0.05% 175
2025
Q4
$251K Hold
1,000
0.05% 183
2025
Q3
$287K Hold
1,000
0.06% 162
2025
Q2
$263K Hold
1,000
0.06% 174
2025
Q1
$233K Hold
1,000
0.07% 178
2024
Q4
$229K Hold
1,000
0.07% 176
2024
Q3
$223K Sell
1,000
-6
-0.6% -$1.32K 0.07% 176
2024
Q2
$205K Buy
1,006
+3
+0.3% +$610 0.07% 168
2024
Q1
$219K Buy
1,003
+3
+0.3% +$661 0.09% 151
2023
Q4
$227K Hold
1,000
0.1% 137
2023
Q3
$201K Sell
1,000
-209
-17% -$44.1K 0.1% 135
2023
Q2
$251K Buy
+1,209
New +$235K 0.13% 118

Other funds holding LH

ABLE Financial Group's LH Position: Q2 2026 in Review

ABLE Financial Group held its Labcorp (LH) position steady in Q2 2026 at 1,000 shares worth $280K. The position accounts for 0.05% of the portfolio, ranked #186.

ABLE Financial Group first reported a position in LH in Q2 2023 and has held it in 13 quarters since. The position peaked at $287K in Q3 2025. 221 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • ABLE Financial Group held 1,000 shares of Labcorp worth $280K as of Q2 2026.
  • ABLE Financial Group left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.05% of ABLE Financial Group's portfolio in Q2 2026, its #186 holding.
  • ABLE Financial Group first reported a position in Labcorp in Q2 2023 and has held it in 13 quarters since.
  • ABLE Financial Group's Labcorp position peaked at $287K in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on ABLE Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.